Healthcare provider profile · identity verified

Dagmar Tobits, M.D.

Family Practice · WILMINGTON, VT · NPI 1982911673

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	440	130
Levothyroxine Sodium	Levothyroxine Sodium	297	77
Lisinopril	Lisinopril	259	80
Amlodipine Besylate	Amlodipine Besylate	257	81
Gabapentin	Gabapentin	245	67
Omeprazole	Omeprazole	204	70
Simvastatin	Simvastatin	171	51
Hydrochlorothiazide	Hydrochlorothiazide	165	53
Losartan Potassium	Losartan Potassium	153	43
Metoprolol Succinate	Metoprolol Succinate	129	34
Albuterol Sulfate Hfa	Albuterol Sulfate	127	45
Allopurinol	Allopurinol	126	33
Alendronate Sodium	Alendronate Sodium	114	31
Ozempic	Semaglutide	113	27
Eliquis	Apixaban	102	25
Trazodone Hcl	Trazodone Hcl	87	23
Metoprolol Tartrate	Metoprolol Tartrate	86	27
Sertraline Hcl	Sertraline Hcl	85	27
Metformin Hcl	Metformin Hcl	81	25
Tamsulosin Hcl	Tamsulosin Hcl	80	24
Pravastatin Sodium	Pravastatin Sodium	79	24
Chlorthalidone	Chlorthalidone	72	21
Fluoxetine Hcl	Fluoxetine Hcl	71	14
Pantoprazole Sodium	Pantoprazole Sodium	66	24
Baclofen	Baclofen	64	18
Bupropion Xl	Bupropion Hcl	64	15
Metformin Hcl Er	Metformin Hcl	64	24
Citalopram Hbr	Citalopram Hydrobromide	63	20
Lorazepam	Lorazepam	63	22
Prednisone	Prednisone	62	36
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	58	13
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	56	suppressed
Ipratropium Bromide	Ipratropium Bromide	53	25
Pregabalin	Pregabalin	50	17
Doxycycline Hyclate	Doxycycline Hyclate	49	37
Zolpidem Tartrate	Zolpidem Tartrate	49	17
Fluticasone Propionate	Fluticasone Propionate	48	26
Rosuvastatin Calcium	Rosuvastatin Calcium	48	17
Buspirone Hcl	Buspirone Hcl	47	13
Montelukast Sodium	Montelukast Sodium	46	16
Furosemide	Furosemide	44	19
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	43	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	43	14
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	40	suppressed
Clopidogrel	Clopidogrel Bisulfate	39	suppressed
Farxiga	Dapagliflozin Propanediol	38	11
Lovastatin	Lovastatin	37	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	37	suppressed
Carvedilol	Carvedilol	35	suppressed
Atenolol	Atenolol	34	12
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	34	suppressed
Torsemide	Torsemide	34	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	34	24
Potassium Chloride	Potassium Chloride	32	12
Tramadol Hcl	Tramadol Hcl	32	suppressed
Duloxetine Hcl	Duloxetine Hcl	31	11
Meloxicam	Meloxicam	31	14
Paxlovid	Nirmatrelvir/Ritonavir	31	29
Warfarin Sodium	Warfarin Sodium	30	11
Amitriptyline Hcl	Amitriptyline Hcl	29	suppressed
Famotidine	Famotidine	28	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	27	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	26	suppressed
Diazepam	Diazepam	26	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	24	18
Benazepril Hcl	Benazepril Hcl	24	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	24	20
Valsartan	Valsartan	24	suppressed
Bupropion Hcl Sr	Bupropion Hcl	23	suppressed
Folic Acid	Folic Acid	22	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	22	suppressed
Spironolactone	Spironolactone	22	suppressed
Ventolin Hfa	Albuterol Sulfate	22	suppressed
Azithromycin	Azithromycin	21	20
Estradiol	Estradiol	21	suppressed
Oxycodone Hcl	Oxycodone Hcl	21	suppressed
Synthroid	Levothyroxine Sodium	21	suppressed
Breo Ellipta	Fluticasone/Vilanterol	20	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	19	suppressed
Finasteride	Finasteride	19	suppressed
Ibuprofen	Ibuprofen	19	suppressed
Topiramate	Topiramate	19	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	18	suppressed
Bupropion Hcl	Bupropion Hcl	18	suppressed
Clonazepam	Clonazepam	18	suppressed
Myrbetriq	Mirabegron	18	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	18	suppressed
Morphine Sulfate Er	Morphine Sulfate	17	suppressed
Amoxicillin	Amoxicillin	16	11
Ezetimibe	Ezetimibe	16	suppressed
Morphine Sulfate	Morphine Sulfate	16	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	16	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	15	suppressed
Methimazole	Methimazole	15	suppressed
Nystatin	Nystatin	15	13
Sumatriptan Succinate	Sumatriptan Succinate	15	suppressed
Tresiba Flextouch U-100	Insulin Degludec	15	suppressed
Trulicity	Dulaglutide	15	suppressed
Cephalexin	Cephalexin	14	suppressed
Dulera	Mometasone/Formoterol	14	suppressed
Glipizide Er	Glipizide	14	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	14	suppressed
Sucralfate	Sucralfate	14	suppressed
Dextroamphetamine Sulfate	Dextroamphetamine Sulfate	13	suppressed
Methadone Hcl	Methadone Hcl	13	suppressed
Oxycontin	Oxycodone Hcl	13	suppressed
Solifenacin Succinate	Solifenacin Succinate	13	suppressed
Symbicort	Budesonide/Formoterol Fumarate	13	suppressed
Valacyclovir	Valacyclovir Hcl	13	suppressed
Verapamil Er	Verapamil Hcl	13	suppressed
Fluconazole	Fluconazole	12	suppressed
Glimepiride	Glimepiride	12	suppressed
Januvia	Sitagliptin Phosphate	12	suppressed
Mirtazapine	Mirtazapine	12	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	12	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	12	suppressed
Tiadylt Er	Diltiazem Hcl	12	suppressed
Verapamil Sr	Verapamil Hcl	12	suppressed
Xarelto	Rivaroxaban	12	suppressed
Xtampza Er	Oxycodone Myristate	12	suppressed
Alprazolam	Alprazolam	11	suppressed
Cholestyramine Light	Cholestyramine	11	suppressed
Tresiba Flextouch U-200	Insulin Degludec	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error